REGENXBIO, Inc. (RGNX)
8.57
-0.51
(-5.62%)
USD |
NASDAQ |
Mar 13, 16:00
8.56
-0.01
(-0.12%)
After-Hours: 20:00
REGENXBIO Total Liabilities (Quarterly) : 350.30M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 2.209B |
| AbbVie, Inc. | 137.19B |
| Replimune Group, Inc. | 123.05M |
| BioMarin Pharmaceutical, Inc. | 1.507B |
| Altimmune, Inc. | 55.04M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 453.03M |
| Shareholders Equity (Quarterly) | 102.73M |
| Debt to Equity Ratio | 2.536 |
| Current Ratio | 2.382 |
| Net Debt Paydown Yield | -3.13% |